Healthcare provider profile · identity verified

David E Nicklin, MD

Family Practice · PHILADELPHIA, PA · NPI 1689602724

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	351	106
Omeprazole	Omeprazole	155	51
Metoprolol Succinate	Metoprolol Succinate	129	41
Metformin Hcl Er	Metformin Hcl	127	38
Amlodipine Besylate	Amlodipine Besylate	121	36
Eliquis	Apixaban	114	23
Levothyroxine Sodium	Levothyroxine Sodium	98	27
Olmesartan Medoxomil	Olmesartan Medoxomil	94	28
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	93	12
Albuterol Sulfate Hfa	Albuterol Sulfate	89	30
Furosemide	Furosemide	89	28
Ibuprofen	Ibuprofen	89	32
Gabapentin	Gabapentin	84	26
Spironolactone	Spironolactone	68	24
Tamsulosin Hcl	Tamsulosin Hcl	66	20
Rosuvastatin Calcium	Rosuvastatin Calcium	62	22
Simvastatin	Simvastatin	61	17
Hydrochlorothiazide	Hydrochlorothiazide	57	17
Oxycodone Hcl	Oxycodone Hcl	57	suppressed
Famotidine	Famotidine	56	13
Acetaminophen-Codeine	Acetaminophen With Codeine	55	suppressed
Losartan Potassium	Losartan Potassium	54	18
Nifedipine Er	Nifedipine	54	15
Prednisone	Prednisone	54	23
Lisinopril	Lisinopril	51	16
Pravastatin Sodium	Pravastatin Sodium	51	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	15
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	46	15
Temazepam	Temazepam	45	suppressed
Allopurinol	Allopurinol	43	13
Alprazolam	Alprazolam	43	18
Diclofenac Sodium	Diclofenac Sodium	43	16
Clonazepam	Clonazepam	42	suppressed
Potassium Chloride	Potassium Chloride	42	12
Pregabalin	Pregabalin	41	suppressed
Carvedilol	Carvedilol	39	11
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	39	12
Tramadol Hcl	Tramadol Hcl	39	13
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	38	13
Lorazepam	Lorazepam	37	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	36	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	34	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	34	12
Alendronate Sodium	Alendronate Sodium	33	suppressed
Celecoxib	Celecoxib	32	13
Metformin Hcl	Metformin Hcl	32	11
Xarelto	Rivaroxaban	32	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Finasteride	Finasteride	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	30	suppressed
Sertraline Hcl	Sertraline Hcl	30	suppressed
Solifenacin Succinate	Solifenacin Succinate	30	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Trazodone Hcl	Trazodone Hcl	28	13
Warfarin Sodium	Warfarin Sodium	27	suppressed
Colchicine	Colchicine	26	suppressed
Entresto	Sacubitril/Valsartan	26	suppressed
Glipizide Er	Glipizide	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Naproxen	Naproxen	26	suppressed
Clobetasol Propionate	Clobetasol Propionate	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	25	11
Donepezil Hcl	Donepezil Hcl	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Olanzapine	Olanzapine	24	suppressed
Valsartan	Valsartan	23	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	22	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Atenolol	Atenolol	20	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Jardiance	Empagliflozin	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	16
Trulicity	Dulaglutide	20	suppressed
Ammonium Lactate	Ammonium Lactate	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	19	suppressed
Ozempic	Semaglutide	19	suppressed
Mupirocin	Mupirocin	18	13
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Diazepam	Diazepam	16	suppressed
Duloxetine Hcl	Duloxetine Hcl	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Terbinafine Hcl	Terbinafine Hcl	16	11
Testosterone	Testosterone	16	suppressed
Topiramate	Topiramate	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Cephalexin	Cephalexin	14	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	14	suppressed
Glipizide	Glipizide	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Azithromycin	Azithromycin	13	13
Butorphanol Tartrate	Butorphanol Tartrate	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Orgovyx	Relugolix	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Amlodipine-Valsartan-Hctz	Amlodipine/Valsartan/Hcthiazid	12	suppressed
Montelukast Sodium	Montelukast Sodium	12	suppressed
Abiraterone Acetate	Abiraterone Acetate	11	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	11	suppressed
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error